Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review
M Lv, X Luo, Q Shen, R Lei, X Liu, E Liu, Q Li, Y Chen - Vaccines, 2021 - mdpi.com
Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in
children and adolescents. Methods: We conducted a systematic review of published studies …
children and adolescents. Methods: We conducted a systematic review of published studies …
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
Efficacy, immunogenicity, and safety of COVID-19 vaccines in patients with autoimmune diseases: A systematic review and meta-analysis
A Widhani, AS Hasibuan, R Rismawati, S Maria… - Vaccines, 2023 - mdpi.com
Patients with autoimmune diseases are among the susceptible groups to COVID-19
infection because of the complexity of their conditions and the side effects of the …
infection because of the complexity of their conditions and the side effects of the …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study
Objective Considering the concerns regarding the coronavirus disease‐2019 (COVID‐19)
vaccine safety among pediatric patients with inflammatory rheumatic diseases (IRD) due to a …
vaccine safety among pediatric patients with inflammatory rheumatic diseases (IRD) due to a …
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 …
Background We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
Current take on systemic sclerosis patients' vaccination recommendations
G Murdaca, G Noberasco, D Olobardi, C Lunardi… - Vaccines, 2021 - mdpi.com
Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The
prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ …
prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ …
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
BF Kocyigit, A Akyol - Rheumatology International, 2021 - Springer
As the most well-known and popular video-sharing platform around the world, YouTube is
an influential tool for the dissemination of health-related information. In addition, considering …
an influential tool for the dissemination of health-related information. In addition, considering …
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy …
Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine
breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and …
breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and …
[HTML][HTML] Вакцинация против SARS-CoV-2 при ревматических заболеваниях: вопросы безопасности
БС Белов, АМ Лила, ЕЛ Насонов - Научно-практическая …, 2022 - cyberleninka.ru
Проблема коронавирусной болезни 2019 (COVID-19, coronavirus disease 2019) спустя
два года по-прежнему остается актуальной как в социальном, так и в медицинском …
два года по-прежнему остается актуальной как в социальном, так и в медицинском …